Hamad Saeed Alqahtani¹*, Wael Saeed Alshehri¹, Raad Saleh  Alshaikhi², Firas Abdulkareem AlAmmar¹, Ali Ahmed Alghanmi¹, Mohammed Ali Alghamdi¹, Thamer Hassan Alshehri¹, Mohammed Mofareh Alshehri¹, Nawaf Ayed AlQahtani¹, Turki Ibrahim Assiri², Adel Muidh Alqurashi², Faisal Salem Alghamdi² and Ghanem Ali Alhiqwi¹

¹Respiratory Therapist, Respiratory Care Services, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
²Medical Laboratory Specialist, Virology Lab, Prince Sultan Medical Military City, Riyadh, Saudi Arabia

*Corresponding Author: Hamad Saeed Alqahtani, Respiratory Therapist, Respiratory Care Services, Pediatric Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Received: December 02, 2024; Published: December 11, 2024

Abstract

Aim: This study aimed to evaluate the VBG clinical application value in COPD diagnosis, and VBG, ABG differences in this diagnosis.

Method: The PRISMA standards were followed in the conduct of this study. Databases used include; Medline, EMBASE, and Google Scholar. The search was carried out for articles published in the period from 2006 to 2024. The target articles' whole texts were acquired in compliance with the predetermined inclusion criteria.

Result and Conclusion: Following a round of inspections, 173 substandard and unnecessary articles were removed. The study eventually comprised six papers that satisfied the inclusion criteria. The pH values of the COPD patients' ABG and VBG tests were analyzed and compared in four of the chosen articles. These studies demonstrated that there was no discernible variation between the ABG and VBG in the pH test results of the COPD patients who were having an acute exacerbation.

 Keywords: Venous Blood Gas; Chronic Obstructive Pulmonary Disease; Acute Exacerbation

References

1. Halpin DMG., et al. “Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease”. American Journal of Respiratory and Critical Care Medicine 1 (2021): 24-36.
2. MacLeod M., et al. “Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact”. Respirology 6 (2021): 532-551.
3. Byanova K., et al. “Chronic obstructive pulmonary disease in HIV”. Expert Review of Respiratory Medicine 1 (2021): 71-87.
4. Hanania NA and O’Donnell DE. “Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions”. International Journal of Chronic Obstructive Pulmonary Disease 14 (2019): 1127-1138.
5. Katzenberg G., et al. “Management of chronic obstructive pulmonary disease”. British Journal of Hospital Medicine 7 (2021): 1-10.
6. Ferrera MC., et al. “Advances in Chronic Obstructive Pulmonary Disease”. Annual Review of Medicine 1 (2017): 119-134.
7. Page MJ., et al. “The PRISMA 2020 statement: an updated guideline for reporting systematic reviews”. BMJ (2021): n71.
8. McKeever TM., et al. “Using venous blood gas analysis in the assessment of COPD exacerbations: a prospective cohort study”. Thorax3 (2016): 210-215.
9. Kelly A and Klim S. “Agreement between arterial and venous <scp>pH</scp> and <scp> <scp> pCO 2 </scp> </scp> in patients undergoing non‐invasive ventilation in the emergency department”. Emergency Medicine Australasia 3 (2013): 203-206.
10. McCanny P., et al. “Venous vs arterial blood gases in the assessment of patients presenting with an exacerbation of chronic obstructive pulmonary disease”. American Journal of Emergency Medicine6 (2012): 896-900.
11. O’Connor TM., et al. “Comparison of Arterial and Venous Blood Gases and the Effects of Analysis Delay and Air Contamination on Arterial Samples in Patients with Chronic Obstructive Pulmonary Disease and Healthy Controls”. Respiration 1 (2011): 18-25.
12. Ibrahim I., et al. “Point-of-Care Bedside Gas Analyzer: Limited Use of Venous pCO2 in Emergency Patients”. Journal of Emergency Medicine2 (2011): 117-123.
13. Ak A., et al. “Prediction of Arterial Blood Gas Values from Venous Blood Gas Values in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease”. Tohoku Journal of Experimental Medicine 4 (2006): 285-290.
14. Lim BL and Kelly AM. “A meta-analysis on the utility of peripheral venous blood gas analyses in exacerbations of chronic obstructive pulmonary disease in the emergency department”. European Journal of Emergency Medicine 5 (2010): 246-248.
15. Wilson BJ., et al. “The accuracy of pulse oximetry in emergency department patients with severe sepsis and septic shock: a retrospective cohort study”. BMC Emergency Medicine 1 (2010): 9.
16. Kelly A. “Review article: Can venous blood gas analysis replace arterial in emergency medical care”. Emergency Medicine Australasia6 (2010): 493-498.
17. Rudkin SE., et al. “Prospective correlation of arterial vs venous blood gas measurements in trauma patients”. American Journal of Emergency Medicine 8 (2012): 1371-1377.
18. Kelly AM., et al. “Venous pCO2 and pH can be used to screen for significant hypercarbia in emergency patients with acute respiratory disease”. Journal of Emergency Medicine 1 (2002): 15-19.
19. Razi E and Moosavi GA. “Comparison of arterial and venous blood gas analysis in patients with chronic obstructive pulmonary disease”. Saudi Medical Journal 28 (2007): 862-865.

Citation

Citation: Hamad Saeed Alqahtani., et al. “Clinical Diagnostic Value of Venous Blood Gas for Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbation; Systematic Review”.Acta Scientific Medical Sciences 9.1 (2025): 39-43.

Copyright

Copyright: © 2025 Hamad Saeed Alqahtani., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.